Key Takeaways Tesla’s Robotaxi trial in Austin has shown early success in operational reliability and safety, setting a positive technical precedent for future expansion. The company has demonstrated significant pricing...
Key Takeaways Quantum BioPharma, a biotech firm focused on neurodegenerative therapies, has acquired a small, strategic stake of 2,000 shares in GameStop Corp. The move signals a curious diversification strategy,...
Key Takeaways Oscar Health forecasts strong revenue of $12.1 billion for 2025, significantly above consensus, but projects an adjusted EBITDA loss of $130 million against expectations of a profit. The...
The race to dominate artificial intelligence infrastructure has taken a significant turn with the expanded partnership between Oracle and OpenAI, targeting an ambitious 4.5 gigawatts of data centre capacity in...
Key Takeaways The healthcare sector is experiencing significant capital outflows in mid-2025, creating a potential valuation disconnect despite strong underlying fundamentals such as an ageing population. Established players like UnitedHealth...
Key Takeaways Rocket Lab’s strategy of vertical integration for the Space Development Agency’s T2TL-Beta programme provides a significant competitive advantage by controlling the entire satellite lifecycle. The company is responsible...
The payments sector in emerging markets has been a focal point for investors seeking growth beyond saturated developed economies, and DLocal Limited (NASDAQ: DLO) stands out as a compelling case....
The health insurance industry in 2024 has shown remarkable progress in customer satisfaction metrics, with certain players achieving standout results in Net Promoter Scores (NPS) and retention rates. Notably, some...
The sharpest insight into Oscar Health (OSCR) lies in its ambitious earnings trajectory amidst a volatile healthcare insurance landscape. With management projecting an earnings per share (EPS) of $2.25 by...
Key Takeaways ACA enrollment growth is decelerating, with significant policy risks looming as enhanced federal subsidies are scheduled to expire at the end of 2025. Oscar Health (OSCR) posted strong...
